title: Calcium-regulated protein kinases and low Km cGMP phosphodiesterases: targets for novel antihypertensive therapy.
authors.affiliation: Department of Cardiovascular Pharmacology, Sterling Research Group, Rensselaer, NY 12144.
authors.forename: P J
authors.initials: PJ
authors.lastname: Silver
authors.forename: E D
authors.initials: ED
authors.lastname: Pagani
authors.forename: W R
authors.initials: WR
authors.lastname: Cumiskey
authors.forename: R L
authors.initials: RL
authors.lastname: Dundore
authors.forename: A L
authors.initials: AL
authors.lastname: Harris
authors.forename: K C
authors.initials: KC
authors.lastname: Lee
authors.forename: A M
authors.initials: AM
authors.lastname: Ezrin
authors.forename: R A
authors.initials: RA
authors.lastname: Buchholz
mesh_terms: D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000378:metabolism*; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000201:enzymology; D009219:Myosin-Light-Chain Kinase / Q000378:metabolism; D011493:Protein Kinase C / Q000378:metabolism; D011494:Protein Kinases / Q000378:metabolism*
chemical_list: D000959:Antihypertensive Agents; D011494:Protein Kinases; D011493:Protein Kinase C; D009219:Myosin-Light-Chain Kinase; D015106:3',5'-Cyclic-GMP Phosphodiesterases